Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct 18:29:100812.
doi: 10.1016/j.ymgmr.2021.100812. eCollection 2021 Dec.

The diagnostic rate of inherited metabolic disorders by exome sequencing in a cohort of 547 individuals with developmental disorders

Affiliations
Review

The diagnostic rate of inherited metabolic disorders by exome sequencing in a cohort of 547 individuals with developmental disorders

Julian Delanne et al. Mol Genet Metab Rep. .

Abstract

Considering that some Inherited Metabolic Disorders (IMDs) can be diagnosed in patients with no distinctive clinical features of IMDs, we aimed to evaluate the power of exome sequencing (ES) to diagnose IMDs within a cohort of 547 patients with unspecific developmental disorders (DD). IMDs were diagnosed in 12% of individuals with causative diagnosis (177/547). There are clear benefits of using ES in DD to diagnose IMD, particularly in cases where biochemical studies are unavailable.

Synopsis: Exome sequencing and diagnostic rate of Inherited Metabolic Disorders in individuals with developmental disorders.

Keywords: Developmental delay; Exome sequencing; Genotype first; Inherited metabolic disorders; Intellectual disability.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Saudubray J.-M., Garcia-Cazorla A. An overview of inborn errors of metabolism affecting the brain: from neurodevelopment to neurodegenerative disorders. Dialogues Clin. Neurosci. 2018;20:301–325. - PMC - PubMed
    1. Ezgu F. Inborn errors of metabolism. Adv. Clin. Chem. 2016;73:195–250. - PubMed
    1. Tarailo-Graovac M., Wasserman W.W., Van Karnebeek C.D.M. Impact of next-generation sequencing on diagnosis and management of neurometabolic disorders: current advances and future perspectives. Expert. Rev. Mol. Diagn. 2017;17:307–309. - PubMed
    1. Ghosh A., Schlecht H., Heptinstall L.E. Diagnosing childhood-onset inborn errors of metabolism by next-generation sequencing. Arch. Dis. Child. 2017;102:1019–1029. - PubMed
    1. Nambot S., Thevenon J., Kuentz P. Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: substantial interest of prospective annual reanalysis. Genet Med. 2018;20:645–654. - PubMed

LinkOut - more resources